{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:09Z","timestamp":1793158149762,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2026MS1142"],"award-info":[{"award-number":["ZR2026MS1142"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970850"],"award-info":[{"award-number":["31970850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404713"],"award-info":[{"award-number":["82404713"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270939"],"award-info":[{"award-number":["32270939"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.autrev.2026.104183","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:19:22Z","timestamp":1788995962000},"page":"104183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunomodulatory mechanisms of bile acids in autoimmune diseases along the gut-liver axis"],"prefix":"10.1016","volume":"25","author":[{"given":"Shuangling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huazhang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10391","key":"10.1016\/j.autrev.2026.104183_bb0005","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK [J]","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders [J]","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.autrev.2026.104183_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease [J]","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, Progress, and prospects of developing therapies to treat autoimmune diseases [J]","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.autrev.2026.104183_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70262","article-title":"Autoimmune diseases: molecular pathogenesis and therapeutic targets [J]","volume":"6","author":"Song","year":"2020","journal-title":"MedComm"},{"issue":"7","key":"10.1016\/j.autrev.2026.104183_bb0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs [J]","volume":"385","author":"Schett","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.autrev.2026.104183_bb0035","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","article-title":"Immune-mediated inflammatory disease therapeutics: past, present and future [J]","volume":"21","author":"Mcinnes","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104183_bb0040","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240806","article-title":"Targeting TNF\/TNFR superfamilies in immune-mediated inflammatory diseases [J]","volume":"221","author":"Veerasubramanian","year":"2024","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12858","article-title":"Immunometabolism: from basic mechanisms to translation [J]","volume":"295","author":"Makowski","year":"2020","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002084","article-title":"Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases [J]","volume":"21","author":"Blanco","year":"2023","journal-title":"PLoS Biol"},{"issue":"7809","key":"10.1016\/j.autrev.2026.104183_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells [J]","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104183_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2024.101291","article-title":"Immunology of bile acids regulated receptors [J]","volume":"95","author":"Fiorucci","year":"2024","journal-title":"Prog Lipid Res"},{"issue":"8000","key":"10.1016\/j.autrev.2026.104183_bb0065","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41586-024-07017-8","article-title":"Bile salt hydrolase acyltransferase activity expands bile acid diversity [J]","volume":"626","author":"Guzior","year":"2024","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.autrev.2026.104183_bb0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41575-024-00896-2","article-title":"Another renaissance for bile acid gastrointestinal microbiology [J]","volume":"21","author":"Ridlon","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/j.autrev.2026.104183_bb0080","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41577-024-01057-x","article-title":"How bile acids and the microbiota interact to shape host immunity [J]","volume":"24","author":"Lee","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"10.1016\/j.autrev.2026.104183_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169096","article-title":"Bile acid signaling in inflammatory bowel disease [J]","volume":"22","author":"Bromke","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2026.104183_bb0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/19490976.2019.1674124","article-title":"Diversification of host bile acids by members of the gut microbiota [J]","volume":"11","author":"Winston","year":"2020","journal-title":"Gut Microbes"},{"issue":"7903","key":"10.1016\/j.autrev.2026.104183_bb0095","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","article-title":"Human gut bacteria produce \u03a4(\u0397)17-modulating bile acid metabolites [J]","volume":"603","author":"Paik","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104183_bb0100","article-title":"Gut microbiota-derived metabolites modulate Treg\/Th17 balance: novel therapeutic targets in autoimmune diseases [J]","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104183_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","article-title":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation [J]","volume":"28","author":"Thibaut","year":"2022","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation [J]","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.autrev.2026.104183_bb0115","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/j.gastro.2024.01.049","article-title":"Immunopathogenesis of primary biliary cholangitis, primary Sclerosing cholangitis and autoimmune hepatitis: themes and concepts [J]","volume":"166","author":"Trivedi","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104183_bb0120","article-title":"The bridge of the gut-joint axis: gut microbial metabolites in rheumatoid arthritis [J]","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"issue":"7790","key":"10.1016\/j.autrev.2026.104183_bb0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis [J]","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease [J]","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-immunol-090222-102035","article-title":"Microbial metabolites and gut immunology [J]","volume":"42","author":"Takeuchi","year":"2024","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease [J]","volume":"82","author":"Fuchs","year":"2025","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104183_bb0145","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s11427-023-2353-0","volume":"67","year":"2024","journal-title":"Sci China Life Sci"},{"issue":"8000","key":"10.1016\/j.autrev.2026.104183_bb0150","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41586-023-06990-w","article-title":"Bile salt hydrolase catalyses formation of amine-conjugated bile acids [J]","volume":"626","author":"Rimal","year":"2024","journal-title":"Nature"},{"issue":"7813","key":"10.1016\/j.autrev.2026.104183_bb0155","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome [J]","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.autrev.2026.104183_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.02.019","article-title":"The underappreciated diversity of bile acid modifications [J]","volume":"187","author":"Mohanty","year":"2024","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.autrev.2026.104183_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116046","article-title":"Molecular basis of bile acid-FXR-FGF15\/19 signaling Axis [J]","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.autrev.2026.104183_bb0170","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy [J]","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104183_bb0175","article-title":"Pleiotropic immunoregulation by bile acids in pathophysiology [J]","volume":"17","author":"Lin","year":"2026","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104183_bb0180","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer [J]","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104183_bb0185","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fimmu.2019.01070","article-title":"Nuclear receptors regulate intestinal inflammation in the context of IBD [J]","volume":"10","author":"Klepsch","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104183_bb0190","article-title":"Bile acid-mediated gut-liver axis crosstalk: the role of nuclear receptor signaling in dynamic regulation of inflammatory networks [J]","volume":"16","author":"Yan","year":"2025","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0195","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 Inflammasome [J]","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104183_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2026.1747341","article-title":"The role of bile acid-activated receptor TGR5 in inflammation and liver diseases [J]","volume":"17","author":"Xiang","year":"2026","journal-title":"Front Physiol"},{"key":"10.1016\/j.autrev.2026.104183_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107779","article-title":"The intestinal functions of PXR and CAR [J]","volume":"216","author":"Feng","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.autrev.2026.104183_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1692684","article-title":"Recent advances in gut microbiota metabolite regulation of hepatic pregnane X receptor [J]","volume":"16","author":"Lin","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0215","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00018-025-05834-2","article-title":"Lithocholic acid ameliorates ulcerative colitis via the PXR\/TLR4\/NF-\u03baB\/NLRP3 signaling pathway and gut microbiota modulation [J]","volume":"82","author":"Liu","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2026.104183_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1761552","article-title":"Pregnane X receptor (NR1I2) deficiency in mice reveals context-dependent regulation of inflammatory homeostasis [J]","volume":"17","author":"Amini","year":"2026","journal-title":"Front Immunol"},{"issue":"7785","key":"10.1016\/j.autrev.2026.104183_bb0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation [J]","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"issue":"36","key":"10.1016\/j.autrev.2026.104183_bb0230","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","article-title":"Novel insight into mechanisms of cholestatic liver injury [J]","volume":"18","author":"Woolbright","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"10457","key":"10.1016\/j.autrev.2026.104183_bb0235","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis [J]","volume":"404","author":"Tanaka","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0240","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/HEP.0000000000000611","article-title":"Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1 [J]","volume":"79","author":"Zhuang","year":"2024","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.autrev.2026.104183_bb0245","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cgh.2023.02.005","article-title":"New treatment paradigms in primary biliary cholangitis [J]","volume":"21","author":"Levy","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/HEP.0000000000000728","article-title":"Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis [J]","volume":"80","author":"Kremer","year":"2024","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0255","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1515\/mr-2024-0020","article-title":"Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases [J]","volume":"4","author":"Wang","year":"2024","journal-title":"Med Rev (2021)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/HEP.0000000000000529","article-title":"Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: to what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? [J]","volume":"79","author":"Corpechot","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.08.003","article-title":"Gut microbiome pattern impacts treatment response in primary biliary cholangitis [J]","volume":"6","author":"Liu","year":"2025","journal-title":"Med"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0270","first-page":"855","article-title":"Primary biliary cholangitis and the narrowing gap towards optimal disease control [J]. Lancet","volume":"10","author":"Can\u00e7ado","year":"2025","journal-title":"Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104183_bb0275","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jhep.2025.06.010","article-title":"The history and future of bile acid therapies [J]","volume":"83","author":"Beuers","year":"2025","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0280","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of Elafibranor in primary biliary cholangitis [J]","volume":"390","author":"Kowdley","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104183_bb0285","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jhep.2021.01.013","article-title":"A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA [J]","volume":"74","author":"Schattenberg","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0290","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of Seladelpar in primary biliary cholangitis [J]","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2468-1253(25)00192-X","article-title":"Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial [J]","volume":"11","author":"Hirschfield","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0300","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/HEP.0000000000001166","article-title":"Primary biliary cholangitis: personalizing second-line therapies [J]","volume":"82","author":"Levy","year":"2025","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.autrev.2026.104183_bb0305","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis [J]","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093143","article-title":"Bile acid-gut microbiota axis in inflammatory bowel disease: from bench to bedside [J]","volume":"13","author":"Yang","year":"2021","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.autrev.2026.104183_bb0315","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/gutjnl-2022-328048","article-title":"Faecal metabolome and its determinants in inflammatory bowel disease [J]","volume":"72","author":"Vich Vila","year":"2023","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.autrev.2026.104183_bb0320","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/gutjnl-2023-329969","article-title":"Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases [J]","volume":"73","author":"Vich Vila","year":"2024","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.autrev.2026.104183_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.06.019","article-title":"Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease [J]","volume":"29","author":"Lee","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.autrev.2026.104183_bb0330","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology [J]","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104183_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101210","article-title":"Bile acids and their receptors in regulation of gut health and diseases [J]","volume":"89","author":"Lin","year":"2023","journal-title":"Prog Lipid Res"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.06.008","article-title":"TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response [J]","volume":"36","author":"Zheng","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2026.104183_bb0345","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jare.2024.03.026","article-title":"Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice [J]","volume":"69","author":"Li","year":"2025","journal-title":"J Adv Res"},{"issue":"45","key":"10.1016\/j.autrev.2026.104183_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202505208","article-title":"Honeysuckle-derived Nanovesicles regulate gut microbiota for the treatment of inflammatory bowel disease [J]","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0355","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.stem.2022.08.008","article-title":"Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal [J]","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.autrev.2026.104183_bb0360","article-title":"Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review [J]","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104183_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1667391","article-title":"Metabolomics in autoimmune hepatitis: progress and perspectives [J]","volume":"12","author":"Huang","year":"2025","journal-title":"Front Med"},{"issue":"39","key":"10.1016\/j.autrev.2026.104183_bb0370","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.3748\/wjg.v28.i39.5764","article-title":"Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis [J]","volume":"28","author":"Ma","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104183_bb0375","article-title":"3-O-Acetyloleanolic acid alleviates autoimmune liver injury by targeting FXR [J]","volume":"148","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.autrev.2026.104183_bb0380","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1142\/S0192415X23500209","article-title":"Efficacy and safety of Glycyrrhizic acid in treatment of autoimmune hepatitis [J]","volume":"51","author":"Bi","year":"2023","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.autrev.2026.104183_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116365","article-title":"Tripterygium wilfordii protects against an animal model of autoimmune hepatitis [J]","volume":"309","author":"Zhang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.autrev.2026.104183_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1636007","article-title":"Integrated analysis of fecal microbiota and metabolomics reveals unique characteristics of asymptomatic and classic celiac disease [J]","volume":"16","author":"Yao","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2026.104183_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1607899","article-title":"Bile acids affect intestinal barrier function through FXR and TGR5 [J]","volume":"12","author":"Song","year":"2025","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0400","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/gutjnl-2025-335373","article-title":"Coeliac disease and the intestinal barrier: mechanisms of disruption and strategies for restoration [J]","volume":"75","author":"Damianos","year":"2026","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13062-025-00633-y","article-title":"The CXCR3\/PLC\/IP3-IP3R axis is responsible for the ignition of UPR in intestinal epithelial cells exposed to gliadin peptide, during the onset of celiac disease [J]","volume":"20","author":"Monzani","year":"2025","journal-title":"Biol Direct"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-022-01429-2","article-title":"Dynamics of the gut microbiome, IgA response, and plasma metabolome in the development of pediatric celiac disease [J]","volume":"11","author":"Girdhar","year":"2023","journal-title":"Microbiome"},{"issue":"6","key":"10.1016\/j.autrev.2026.104183_bb0415","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41590-025-02146-2","article-title":"Immune-epithelial-stromal networks define the cellular ecosystem of the small intestine in celiac disease [J]","volume":"26","author":"Fitzpatrick","year":"2025","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104183_bb0420","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis [J]","volume":"20","author":"Hov","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0425","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41572-025-00600-x","article-title":"Primary sclerosing cholangitis [J]","volume":"11","author":"Manns","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"10.1016\/j.autrev.2026.104183_bb0430","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s12276-023-01042-9","article-title":"Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis [J]","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"issue":"12","key":"10.1016\/j.autrev.2026.104183_bb0435","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/ecco-jcc\/jjae096","article-title":"Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profile [J]","volume":"18","author":"Leibovitzh","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.autrev.2026.104183_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16235","article-title":"Liver GPBAR1 associates with immune dysfunction in primary Sclerosing cholangitis and its activation attenuates cholestasis in Abcb4\u2212\/\u2212 mice [J]","volume":"45","author":"Di Giorgio","year":"2025","journal-title":"Liver Int"},{"issue":"20","key":"10.1016\/j.autrev.2026.104183_bb0445","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170320","article-title":"Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis [J]","volume":"8","author":"Jalan-Sakrikar","year":"2023","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0450","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/HEP.0000000000001093","article-title":"Central role for cholangiocyte pathobiology in cholestatic liver diseases [J]","volume":"82","author":"Jalan-Sakrikar","year":"2025","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0455","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2025.08.021","article-title":"Cellular senescence in liver diseases: from molecular drivers to therapeutic targeting [J]","volume":"84","author":"Du","year":"2026","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0460","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.42288","article-title":"Dysregulation of bile acids, lipids, and nucleotides in psoriatic arthritis revealed by unbiased profiling of serum metabolites [J]","volume":"75","author":"Paine","year":"2023","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0465","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/gutjnl-2022-327756","article-title":"Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis [J]","volume":"72","author":"Sun","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104183_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.166837","article-title":"Chronic cold environment regulates rheumatoid arthritis through modulation of gut microbiota-derived bile acids [J]","volume":"903","author":"Liu","year":"2023","journal-title":"Sci Total Environ"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0475","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13020-025-01123-z","article-title":"Fuzi alleviates cold-related rheumatoid arthritis via regulating gut microbiota and microbial bile acid metabolism [J]","volume":"20","author":"Liu","year":"2025","journal-title":"Chin Med"},{"issue":"12","key":"10.1016\/j.autrev.2026.104183_bb0480","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/art.42635","article-title":"Metabolomics and machine learning identify metabolic differences and potential biomarkers for frequent versus infrequent gout flares [J]","volume":"75","author":"Wang","year":"2023","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104183_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155800","article-title":"Guizhi Shaoyao Zhimu decoction ameliorates gouty arthritis in rats via altering gut microbiota and improving metabolic profile [J]","volume":"131","author":"Bian","year":"2024","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.autrev.2026.104183_bb0490","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.70048","article-title":"Bile acids metabolism in symptomatic hand osteoarthritis [J]","volume":"78","author":"Li","year":"2026","journal-title":"Arthritis Rheum"},{"issue":"6742","key":"10.1016\/j.autrev.2026.104183_bb0495","doi-asserted-by":"crossref","DOI":"10.1126\/science.adt0548","article-title":"Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling [J]","volume":"388","author":"Yang","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104183_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2025.140750","article-title":"Bile acids insufficiency links perfluorooctane sulfonate-induced oxidative stress-mediated fatty liver with osteoarthritis [J]","volume":"501","author":"Yu","year":"2026","journal-title":"J Hazard Mater"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0505","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41574-024-01003-w","article-title":"The relationship between the gut microbiota and thyroid disorders [J]","volume":"20","author":"Ludgate","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104183_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/nu18101501","article-title":"The gut-skin and gut-thyroid Axis in autoimmunity: roles of dysbiosis, microbial metabolites, immune dysregulation, and diet in psoriasis and Hashimoto\u2019s thyroiditis [J]","volume":"18","author":"Riba\u010duka","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.autrev.2026.104183_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1661211","article-title":"Gut microbiota in hypothyroidism: pathogenic mechanisms and opportunities for precision microbiome interventions [J]","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0520","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/art.42863","article-title":"Unique interplay between antinuclear antibodies and nuclear molecules in the pathogenesis of systemic lupus erythematosus [J]","volume":"76","author":"Pisetsky","year":"2024","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0525","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12866-025-03995-5","article-title":"Uncovering potential biomarkers and metabolic pathways in systemic lupus erythematosus and lupus nephritis through integrated microbiome and metabolome analysis [J]","volume":"25","author":"Cheng","year":"2025","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.autrev.2026.104183_bb0530","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3389\/fimmu.2020.01703","article-title":"Microbiome and metabolome analyses reveal the disruption of lipid metabolism in systemic lupus erythematosus [J]","volume":"11","author":"He","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104183_bb0535","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41423-025-01309-3","article-title":"FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus [J]","volume":"22","author":"Wang","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104183_bb0540","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1038\/s44321-026-00478-6","article-title":"Obeticholic acid alleviates lupus pathology by inhibiting T follicular helper cell differentiation [J]","volume":"18","author":"Kang","year":"2026","journal-title":"EMBO Mol Med"},{"issue":"551","key":"10.1016\/j.autrev.2026.104183_bb0545","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2220","article-title":"Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice [J]","volume":"12","author":"Choi","year":"2020","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104183_bb0550","article-title":"Microbiota-mediated skewing of tryptophan catabolism modulates CD4(+) T cells in lupus-prone mice","volume":"25","author":"Brown","year":"2022","journal-title":"[J] iScience"},{"key":"10.1016\/j.autrev.2026.104183_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109939","article-title":"Immmunometabolism of systemic lupus erythematosus [J]","volume":"261","author":"Furment","year":"2024","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104183_bb0560","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin [J]","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0565","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1038\/s41467-024-46441-2","article-title":"Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation [J]","volume":"15","author":"Huang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104183_bb0570","doi-asserted-by":"crossref","DOI":"10.1038\/s41584-026-01421-2","article-title":"Hepatic control of immunometabolism: implications for the pathogenesis, diagnosis and treatment of rheumatic diseases [J]","author":"Perl","year":"2026","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104183_bb0575","article-title":"Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome [J]","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2019.05.003","article-title":"Pathogenic autoreactive T and B cells cross-react with Mimotopes expressed by a common human gut commensal to trigger autoimmunity [J]","volume":"26","author":"Ruff","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103891","article-title":"Primordial and primary prevention in rheumatological diseases: the time has come [J]","volume":"24","author":"Scagnellato","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2026.104183_bb0590","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s44161-025-00637-x","article-title":"The gut microbiota-bile acid-TGR5 axis orchestrates platelet activation and atherothrombosis [J]","volume":"4","author":"Qi","year":"2025","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0595","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/s41467-022-33656-4","article-title":"Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes [J]","volume":"13","author":"Yuan","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.autrev.2026.104183_bb0600","article-title":"Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes [J]","volume":"3","author":"Lamichhane","year":"2022","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104183_bb0605","article-title":"Restoration of intestinal secondary bile acid synthesis: a potential approach to improve pancreatic \u03b2 cell function in type 1 diabetes [J]","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep Med"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0610","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41551-021-00791-0","article-title":"Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin [J]","volume":"5","author":"Lee","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.autrev.2026.104183_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders [J]","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog Lipid Res"},{"issue":"7","key":"10.1016\/j.autrev.2026.104183_bb0620","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis [J]","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0625","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2468-1253(25)00208-0","article-title":"Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial [J]","volume":"11","author":"Trauner","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20230934","article-title":"Bile salt signaling and bile salt-based therapies in cardiometabolic disease [J]","volume":"138","author":"Groenen","year":"2024","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.autrev.2026.104183_bb0635","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2026.05.001","article-title":"Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid [J]","volume":"85","author":"Xiong","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104183_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123095","article-title":"Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier [J]","volume":"357","author":"Shu","year":"2024","journal-title":"Life Sci"},{"issue":"Pt 2","key":"10.1016\/j.autrev.2026.104183_bb0645","article-title":"Rifaximin alleviates intestinal barrier disruption and systemic inflammation via the PXR\/NF\u03baB\/MLCK pathway and modulates intestinal Lachnospiraceae abundance in heat-stroke mice [J]","volume":"143","author":"Du","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"14","key":"10.1016\/j.autrev.2026.104183_bb0650","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146710","article-title":"Rifaximin attenuates liver fibrosis and Hepatocarcinogenesis in a rat MASH model by suppressing the gut-liver Axis and Epiregulin-IL-8-associated angiogenesis [J]","volume":"26","author":"Nishimura","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2026.104183_bb0655","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","article-title":"Rifaximin-\u03b1 reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial [J]","volume":"76","author":"Patel","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0660","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease [J]","volume":"125","author":"Jiang","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104183_bb0665","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction [J]","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.autrev.2026.104183_bb0670","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/apt.15099","article-title":"Systematic review with meta-analysis: the prevalence of bile acid malabsorption and response to colestyramine in patients with chronic watery diarrhoea and previous cholecystectomy [J]","volume":"49","author":"Ruiz-Campos","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.autrev.2026.104183_bb0675","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis [J]","volume":"67","author":"Fickert","year":"2017","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0680","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the mechanisms of faecal microbiota transplantation [J]","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0685","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases [J]","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2026.104183_bb0690","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/s41467-021-23460-x","article-title":"Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis [J]","volume":"12","author":"Van Der Lelie","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104183_bb0695","series-title":"Vedanta Biosciences announces phase 2 study of VE202 in ulcerative colitis did not meet primary endpoint [Z]","author":"Vedanta Biosciences","year":"2025"},{"issue":"16","key":"10.1016\/j.autrev.2026.104183_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.06.019","article-title":"Gut-microbiota-targeted diets modulate human immune status [J]","volume":"184","author":"Wastyk","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2026.104183_bb0705","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-nutr-071816-064634","article-title":"Metabolic effects of intermittent fasting [J]","volume":"37","author":"Patterson","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.autrev.2026.104183_bb0710","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease [J]","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104183_bb0715","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis [J]","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104183_bb0720","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/hep.30552","article-title":"Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis [J]","volume":"70","author":"Honda","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.autrev.2026.104183_bb0725","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.14309\/ajg.0000000000002238","article-title":"Effectiveness of Fenofibrate in treatment-naive patients with primary biliary cholangitis: a randomized clinical trial [J]","volume":"118","author":"Liu","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104183_bb0730","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s40265-024-02075-8","article-title":"Elafibranor: first approval [J]","volume":"84","author":"Blair","year":"2024","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.autrev.2026.104183_bb0735","article-title":"Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy [J]","volume":"6","author":"Stoelinga","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.autrev.2026.104183_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103163","article-title":"Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis [J]","volume":"143","author":"Wang","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104183_bb0745","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jare.2021.11.017","article-title":"Targeted delivery of Chinese herb pair-based berberine\/tannin acid self-assemblies for the treatment of ulcerative colitis [J]","volume":"40","author":"Chen","year":"2022","journal-title":"J Adv Res"},{"issue":"4","key":"10.1016\/j.autrev.2026.104183_bb0750","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00281-022-00940-w","article-title":"Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease [J]","volume":"44","author":"Richardson","year":"2022","journal-title":"Semin Immunopathol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:23:54Z","timestamp":1789748634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":150,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1568997226001977"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104183","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory mechanisms of bile acids in autoimmune diseases along the gut-liver axis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104183"}}